Concussion Active Rehabilitation
Launched by CHILDREN'S NATIONAL RESEARCH INSTITUTE · Jan 29, 2020
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Specific Aims:
To compare the risk of prolonged concussion symptoms (PCS) between an active rehabilitation and a standard care cohort after an acute concussion.
To determine if active rehabilitation compared to routine care reduces the risk of PCS for high-risk patients.
This is a prospective randomized control trial of pediatric patients in the emergency department (ED) diagnosed with an acute concussion. Patients 8-18 years old with an acute concussion diagnosis will be eligible. All patients will receive pedometers to monitor their activity levels. If the patient is in the control gro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient diagnosed with an acute concussion within 48 hours
- • Patient greater than 8 and less than 19 years old
- Exclusion Criteria:
- • Major psychiatric diagnosis (bipolar disorder, major depression, does NOT include ADHD/ADD)
- • Cognitive delay
- • GCS \< 14
- • positive findings on head CT
- • Any patient with intracranial surgery, pathology or instrumentation (e.g. VP shunt, brain tumor etc)
About Children's National Research Institute
Children's National Research Institute is a leading pediatric research organization dedicated to advancing the understanding and treatment of childhood diseases. As an integral part of Children's National Hospital, the institute focuses on innovative clinical trials and translational research that aim to improve health outcomes for children. Through collaborations with academic institutions, industry partners, and community organizations, the institute fosters a multidisciplinary approach to research, emphasizing safety, ethical standards, and the integration of cutting-edge technology in pediatric care. With a commitment to addressing the unique health challenges faced by children, Children's National Research Institute strives to translate research findings into effective therapies and interventions that enhance the quality of life for young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials